Pfizer Invests $650 Million in Groton Manufacturing Technology Center to Expand Clinical Trial Supply Production in Connecticut, US
Pfizer invests $650M in a new Groton Manufacturing Technology Center to produce clinical trial supplies, boosting Connecticut pharma manufacturing by mid-2
Research Desk
Groton, Connecticut, will soon be home to a new Pfizer facility dedicated to producing medicines for clinical trials.
The company announced Thursday, alongside economic development officials, plans to build a Manufacturing Technology Center on its research-and-development campus, backed by a USD 650 million capital investment spread over the next five years.
Pfizer to consolidate Groton clinical manufacturing operations
Details released by AdvanceCT, the state's economic development nonprofit, describe an approximately 220,000-square-foot building that will manufacture clinical active pharmaceutical ingredients and drug products destined for Pfizer-sponsored trials worldwide.
Ground is scheduled to break in the second quarter of 2027, and the company aims to have the center up and running by mid-2031. Beyond its production role, the facility is intended to bring together Pfizer staff who currently work in separate buildings across the Groton campus, consolidating them into one modern, purpose-built location.
Site leadership frames the investment as a continuation of Groton's legacy
Raja Mangipudy, who leads Pfizer's Groton site, said the project builds on decades of scientific work at the location.
In a written statement carried in the AdvanceCT release, he noted that many discoveries advancing the company's pipeline begin in Groton and said the new center will strengthen Pfizer's ability to support clinical research and medicine development for patients globally. Local officials echoed that sentiment.
John Bourdeaux, AdvanceCT's CEO and president, called the investment a significant vote of confidence in Groton, its workforce, and Connecticut's capacity to support biopharmaceutical innovation at a global scale, adding that the center will link scientific discovery with the advanced manufacturing needed for worldwide clinical trials.
Groton Mayor Juliette Parker described Pfizer's presence in both the Town and City of Groton as an extraordinary asset to the community and the southeastern Connecticut region, saying the town looks forward to continued partnership and to the opportunities the facility will create for residents and businesses.
Seven decades of research on the Thames
The campus where the new center will rise has been part of Pfizer's operations since 1959. Spanning 175 acres just off the Thames River, it contains roughly 2.17 million square feet of laboratory and office space, according to the company's website.
Its activities range from clinical development and global clinical supply to drug safety, medicine design, pharmacokinetics, dynamics and metabolism, and pharmaceutical sciences.
Pfizer states on its website that many of the innovations powering its pipeline originate in the Groton laboratories and that nearly every Pfizer medicine is developed, in part, at the site.
Groton's employment and tax landscape
Pfizer employed about 4,000 people in Groton as of last year, making it the town's third largest employer, according to the Town of Groton's annual comprehensive financial report for the 2025 fiscal year. The company is also the second largest local taxpayer, with a taxable assessed value of approximately USD 365 million.
Tracked in the database
Pharmaceutical Manufacturing Investment · North America
Pharmaceutical Manufacturing Investment
North America
Chemical
5 November 2026
2 min read
Tagged
Also read
Biocon Secures European Commission Approval for Pertuzumab Biosimilar Pebrilzo in HER2-Positive Breast Cancer
Nanoform Partners With European CDMO to Manufacture High-Concentration Biologics Under GMP in Germany
LOTTE Biologics Signs First Commercial Manufacturing Agreement for Songdo Plant 1 in South Korea
Live from the tracker
The projects behind these stories
Capacity, capex, stage, contractors and verified contacts for every project we track, updated daily.